Lung carcinoma has consistently ranked as the most prevalent malignancy and foremost contributor to cancer-related mortality in global epidemiology. Despite the paradigm-shifting advancements in molecularly targeted therapies and immune checkpoint inhibitors (... ...

请注册登录后继续浏览